Nothing Special   »   [go: up one dir, main page]

WO1997031016A3 - Nouveaux inhibiteurs des processus lies a la presence de sh2 - Google Patents

Nouveaux inhibiteurs des processus lies a la presence de sh2 Download PDF

Info

Publication number
WO1997031016A3
WO1997031016A3 PCT/US1997/002636 US9702636W WO9731016A3 WO 1997031016 A3 WO1997031016 A3 WO 1997031016A3 US 9702636 W US9702636 W US 9702636W WO 9731016 A3 WO9731016 A3 WO 9731016A3
Authority
WO
WIPO (PCT)
Prior art keywords
mediated processes
new inhibitors
compounds
forms
heteroalkyl
Prior art date
Application number
PCT/US1997/002636
Other languages
English (en)
Other versions
WO1997031016A2 (fr
Inventor
Berkley A Lynch
Manfred Weigele
Original Assignee
Ariad Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ariad Pharma Inc filed Critical Ariad Pharma Inc
Priority to AU22775/97A priority Critical patent/AU2277597A/en
Publication of WO1997031016A2 publication Critical patent/WO1997031016A2/fr
Publication of WO1997031016A3 publication Critical patent/WO1997031016A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention se rapporte à des composés représentés par la formule (I) et à des sels pharmaceutiquement acceptables de ces composés. Dans la formule (I), A est H, R?1, -CO-R1¿ ou -CO-OR1, R1 étant un groupe alkyle, hétéroalkyle, aryle ou hétéroaryle substitué ou non substitué et J étant H ou NO¿2?. Bien que les formes L de ces composés soient actuellement préférées, l'invention englobe également des formes D et des mélanges racémiques.
PCT/US1997/002636 1996-02-23 1997-02-21 Nouveaux inhibiteurs des processus lies a la presence de sh2 WO1997031016A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU22775/97A AU2277597A (en) 1996-02-23 1997-02-21 New inhibitors of sh2-mediated processes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1220396P 1996-02-23 1996-02-23
US60/012,203 1996-02-23

Publications (2)

Publication Number Publication Date
WO1997031016A2 WO1997031016A2 (fr) 1997-08-28
WO1997031016A3 true WO1997031016A3 (fr) 1998-02-19

Family

ID=21753844

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/002636 WO1997031016A2 (fr) 1996-02-23 1997-02-21 Nouveaux inhibiteurs des processus lies a la presence de sh2

Country Status (2)

Country Link
AU (1) AU2277597A (fr)
WO (1) WO1997031016A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730671B2 (en) 1999-03-02 2004-05-04 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathespin S
US6756372B2 (en) 1999-09-13 2004-06-29 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cysteine proteases

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105307B2 (en) 1997-08-30 2006-09-12 Cyclacel, Ltd. Compositions and methods for screening for modulators of enzymatic activity
CA2309792A1 (fr) * 1997-11-12 1999-05-20 William C. Shakespeare Nouveaux inhibiteurs de transduction de signal, compositions les contenant
US6156784A (en) * 1997-12-18 2000-12-05 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as phosphotyrosine mimics
EP1045836B1 (fr) * 1997-12-18 2008-03-05 Boehringer Ingelheim Pharmaceuticals Inc. Pyridones utilisees comme inhibiteurs du domaine sh2 de la famille src
WO1999047529A1 (fr) * 1998-03-18 1999-09-23 Ariad Pharmaceuticals, Inc. Inhibiteurs de transduction de signaux heterocycliques et compositions les contenant
WO2000027802A1 (fr) * 1998-11-12 2000-05-18 Ariad Pharmaceuticals, Inc. Inhibiteurs de transduction de signaux bicycliques, compositions les contenant et utilisation de ces dernieres
US7405210B2 (en) 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
ATE483708T1 (de) 2004-03-08 2010-10-15 Prosidion Ltd Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase
DE602005013275D1 (de) 2004-12-02 2009-04-23 Prosidion Ltd Pyrrolopyridin-2-karbonsäureamide
EP1800673A3 (fr) * 2005-12-23 2007-08-15 Canadian Blood Services Nitrophényles et composés associés et thimérosal pour l'inhibition de la destruction cellulaire ou tissulaire liée à l'immunité
WO2019040109A1 (fr) 2017-08-21 2019-02-28 Celgene Corporation Procédés de préparation de (s)-tert-butyl 4,5-diamino-5-oxopentanoate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996023813A1 (fr) * 1995-02-01 1996-08-08 Affymax Technologies N.V. Peptides et composes se fixant aux domaines sh2

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996023813A1 (fr) * 1995-02-01 1996-08-08 Affymax Technologies N.V. Peptides et composes se fixant aux domaines sh2

Non-Patent Citations (21)

* Cited by examiner, † Cited by third party
Title
AUST. J. CHEMISTRY, vol. 32, no. 4, 1979, pages 923 - 925 *
BIOCHEM. J., vol. 113, no. 2, 1969, pages 369 - 375 *
CHEMICAL ABSTRACTS, vol. 102, no. 21, 27 May 1985, Columbus, Ohio, US; abstract no. 185509, I Z SIEMION ET AL.: "Leucime-enkephaline derivatives" XP002049634 *
CHEMICAL ABSTRACTS, vol. 104, no. 11, 17 March 1986, Columbus, Ohio, US; abstract no. 82165, M ALEKSANDROVA ET AL.: "Synthesis, receptor binding affinities and alpha-MSH releasing activities of TRH analogs" XP002049633 *
CHEMICAL ABSTRACTS, vol. 108, no. 1, 4 January 1988, Columbus, Ohio, US; abstract no. 6390, N PANT ET AL.: "Synthetic analogs of peptide-binding antibiotics" page 611; XP002049632 *
CHEMICAL ABSTRACTS, vol. 108, no. 19, 9 May 1988, Columbus, Ohio, US; abstract no. 167944, J-L MORINIÈRE ET AL.: "The use of hydrolases in organic chemistry; synthesis of amides and ester bonds catalyzed by industrial papain" XP002049631 *
CHEMICAL ABSTRACTS, vol. 111, no. 15, 9 October 1989, Columbus, Ohio, US; abstract no. 134720d, A D HAMILTON ET AL.: "Artificial receptors for biologically active molecules" XP002049630 *
CHEMICAL ABSTRACTS, vol. 113, no. 9, 27 August 1990, Columbus, Ohio, US; abstract no. 78953j, XP002049629 *
CHEMICAL ABSTRACTS, vol. 70, no. 11, 17 March 1969, Columbus, Ohio, US; abstract no. 44247, L A COHEN & L FARBER: "Cleavage of tyrosyl-peptide bonds by electrolytic oxidation" XP002049637 *
CHEMICAL ABSTRACTS, vol. 71, no. 13, 29 September 1969, Columbus, Ohio, US; abstract no. 57012, A CORNISH-BOWDEN ET AL.: "Rate-determining step in pepsin-catalyzed reactions and evidence against an acyl-enzyme intermediate" XP002049636 *
CHEMICAL ABSTRACTS, vol. 91, no. 11, 10 September 1979, Columbus, Ohio, US; abstract no. 91943, F H C STEWART ET AL.: "Preparation of anionic active ester derivatives of amino acids" XP002049635 *
EUR. J. MED. CHEM., vol. 22, no. 4, 1987, pages 347 - 357 *
F H CARPENTER ET AL.: "[Tetrakis(3-nitrotyrosine)] insuline", BIOCHEMISTRY., vol. 19, no. 25, 1980, EASTON, PA US, pages 5926 - 5931, XP002049625 *
H BARTOSZ-BECHOWSKI ET AL.: "Further studies on proctolin analogues modified in position 2 of the peptide chain and their influence on heart-beat frequency of insects", INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH., vol. 36, 1990, COPENHAGEN DK, pages 450 - 456, XP002049628 *
J. INCLUSION PHENOM., vol. 5, no. 1, 1987, pages 109 - 111 *
K BLAHA: "Amino acids and peptides XCV. Synthesis of some diastereoisomeric 2,5-piperazinediones", COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS., vol. 34, no. 12, December 1969 (1969-12-01), PRAGUE CS, pages 4000 - 4005, XP002049627 *
METH. ENZYMOL., vol. 11, 1967, pages 299 - 308 *
N I BAVYKINA ET AL.: "Synthesis of diketopiperazine related to cyclohistidylproline", ZH. OBSHCH. KHIM., vol. 60, no. 1, 1990, pages 170 - 175 *
N PANT & A D HAMILTON: "Carboxylic acid complexation by a synthetic analogue of the "carboxylate-binding pocket" of vancomycin", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY., vol. 110, no. 6, 1988, DC US, pages 2002 - 2003, XP002049626 *
POL. J. PHARMACOL. PHARM., vol. 37, no. 2, 1985, pages 197 - 207 *
PURE APPL. CHEM., vol. 60, no. 4, 1988, pages 533 - 538 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730671B2 (en) 1999-03-02 2004-05-04 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathespin S
US6756372B2 (en) 1999-09-13 2004-06-29 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cysteine proteases

Also Published As

Publication number Publication date
WO1997031016A2 (fr) 1997-08-28
AU2277597A (en) 1997-09-10

Similar Documents

Publication Publication Date Title
CA2165819A1 (fr) Derives de dc-89
AU5571190A (en) Retroviral protease inhibiting compounds
EP1103552A4 (fr) Derives de benzothiepine, leur procede de preparation et leurs utilisations
HK1001963A1 (en) Use of compounds in the preparation of a medicament for the inhibition of a pathological condition
EP0916646A3 (fr) Préparation d'une 2,5-diamino-3-hydroxyhexane substituée
WO1997047270A3 (fr) Nouveaux composes antiviraux
EP1466898A4 (fr) Inhibiteurs de la production/secretion de la proteine amyloide-beta
WO1997031016A3 (fr) Nouveaux inhibiteurs des processus lies a la presence de sh2
WO2002102787A3 (fr) Nouveaux derives d'acide sulfonique
AU2722095A (en) Novel pyrrolocarbazoles
HRP20000304B1 (en) Biphenylamidine derivatives
WO2000046210A3 (fr) Nouveau procede de preparation d'intermediaires pesticides
NZ501896A (en) Process for producing isoxazolidinedione compound
CA2264513A1 (fr) Derives substitues de la benzocycloheptapyridine servant a inhiber la farnesyl-proteine transferase
EP1026162A4 (fr) Agent anti-rhumatismal
CA2112083A1 (fr) Composes aryliques heterocycliques substitues
EP1043311A4 (fr) Derives de biphenylamidine
WO2001055126A3 (fr) Synthese de derives 9-dihydro-paclitaxel hydrosolubles de 9-dihydro-13-acetylbaccatine iii
EP1099690A4 (fr) Composes de beta-lactame monocycliques et inhibiteurs de la chymase les renfermant
CA2293712A1 (fr) Urees cycliques benzo(5,6)cycloheptapyridine et lactames utiles comme inhibiteurs de farnesyl proteine transferase
CA2112061A1 (fr) Composes alkyliques heterocycliques substitues
WO2002060878A1 (fr) Derives de benzimidazolidinone
WO2002059089A3 (fr) Procede de preparation d'analogues d'indene heterocycliques
YU3099A (sh) Novi derivati eritromicina, postupak za njihovo dobijanje i njihova primena
WO2000010992A3 (fr) Composes de d-tocotrienol hydrodispersables ou hydrosolubles et modalites d'elaboration a cet effet

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97530306

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: CA